Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jul;28(7):2159-63.
doi: 10.1589/jpts.28.2159. Epub 2016 Jul 29.

The association of vitamin D with inflammatory cytokines in diabetic peripheral neuropathy

Bulent Bilir  1 , Feti Tulubas  2 , Betul Ekiz Bilir  3 , Neslihan Soysal Atile  3 , Sonat Pinar Kara  1 , Tulay Yildirim  4 , Seyit Ali Gumustas  5 , Birol Topcu  6 , Ozlem Kaymaz  2 , Murat Aydin  2
Affiliations

The association of vitamin D with inflammatory cytokines in diabetic peripheral neuropathy

Bulent Bilir et al. J Phys Ther Sci. 2016 Jul.

Abstract

[Purpose] The effects of vitamin D on the circulating levels of IL-17 and IL-13 were investigated in patients with diabetic peripheral neuropathy, patients with diabetes mellitus type 2 without neuropathy, and healthy controls. [Subjects and Methods] A single-blind controlled clinical study was performed, including70 type 2 diabetic patients with or without diabetic peripheral neuropathy and 33 healthy volunteer controls. The 25(OH)D levels were evaluated using ultra-performance liquid chromatography, and IL-17 and IL-13 levels were assessed using enzyme-linked immunosorbent assays. [Results] The 25(OH) vitamin D concentration was lower in diabetic peripheral neuropathy patients than in diabetes mellitus patients without neuropathy and healthy controls. Similarly, 25(OH)D levels were lower in diabetes mellitus patients than healthy controls. IL-17 and IL-13 levels were higher in diabetes mellitus patients than in controls. Additionally, IL-13 levels were higher in diabetic peripheral neuropathy patients than in diabetes mellitus patients without neuropathy. These differences were statistically significant. There was a significant positive correlation between 25(OH)D and IL-13,and a negative correlation between 25(OH)D andIL-17 in the diabetic and diabetic neuropathy groups. [Conclusion] Vitamin D is a potential modifiable risk factor for diabetic peripheral neuropathy and may regulate inflammatory mediators, e.g., IL-17 and IL-13.

Keywords: Cytokines; Diabetic peripheral neuropathy; Vitamin D.

PubMed Disclaimer

References

    1. Boulton AJ, Vinik AI, Arezzo JC, et al. American Diabetes Association: Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care, 2005, 28: 956–962. - PubMed
    1. Liu Y, Liu SX, Cai Y, et al. : Effects of combined aerobic and resistance training on the glycolipid metabolism and inflammation levels in type 2 diabetes mellitus. J Phys Ther Sci, 2015, 27: 2365–2371. - PMC - PubMed
    1. Yu LN, Yang XS, Hua Z, et al. : [Serum levels of pro-inflammatory cytokines in diabetic patients with peripheral neuropathic pain and the correlation among them]. Zhonghua Yi Xue Za Zhi, 2009, 89: 469–471. - PubMed
    1. Soderstrom LH, Johnson SP, Diaz VA, et al. : Association between vitamin D and diabetic neuropathy in a nationally representative sample: results from 2001–2004 NHANES. Diabet Med, 2012, 29: 50–55. - PMC - PubMed
    1. Shehab D, Al-Jarallah K, Mojiminiyi OA, et al. : Does Vitamin D deficiency play a role in peripheral neuropathy in Type 2 diabetes? Diabet Med, 2012, 29: 43–49. - PubMed